The Importance Of Filter Testing - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Importance Of Filter Testing


Pharmaceutical Technology Europe
Volume 23, Issue 8

How important is filter testing in the pharma industry?


Graham Rideal
Filtration in the pharmaceutical industry covers a wide range of applications from powder processing to liquid purification, such as saline or dextrose solutions. In the case of the former, the advantage of good filtration processes mainly lies in recovering valuable drugs, which can cost in excess of $1 million per kilogram. The advantage here is purely commercial.

For intravenous products, however, good filtration is a matter of life and death; a simple internet search on recalled drugs reveals particulate contaminants from the clearly visible, such as glass fragments, wood fibres and mould, to the invisible, and potentially lethal, bacteriological contamination.

The primary test of a filter begins with the filter medium itself to ensure it is fit for purpose. Thereafter the filter system must be tested in situ. Failure can occur in the filter medium or in the sealing arrangement when assembled.

Porosity

One of the simplest methods of comparing filter media is to test porosity either by air or water flow under prescribed conditions. Lower flow rates or higher back pressures indicate better filter performance.

Bubble point

The flow rate method is refined in the so-called bubble point test. Here, the filter is saturated with a liquid and then a gas (usually air) is pressurised from below. As the pressure increases, the air finds the single largest pore, which is blown out, forming a bubble on the surface: the bubble point. The Washburn equation is then applied to convert the applied pressure into the diameter of the pore.

Porometry

Porometry takes the bubble point one step further by continuing the pressurisation of the filter beyond the bubble point. Successively smaller pores are blown clear by the air pressure until the smallest pore is finally evacuated. The applied pressure versus flow rate profile can then be interpolated to provide complete pore size distribution.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
19%
To all process for new products only
14%
To select process for new products only
24%
To select processes for both new and legacy products
19%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology Europe,
Click here